Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

266
27
Favorite

Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

Reuters2021-08-17

Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.

In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.

It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.

The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.

Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.

That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.

The Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.

Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.

The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.

Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.

Berkshire reported a $46.9 million Organon stake as of June 30.

Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.

In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.

It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

266

Report

Comment（27）

Portfolio50
·2021-08-17
Net seller of stocks and that much cash - not a good sign! Gonna be taking money off the table too (once target profits are hit).
Reply
1
Report
bernardtayet
·2021-08-17
Good to follow up
Reply
1
Report
sickeninglim
·2021-08-17
Wow......
Reply
1
Report
HENRYCSC
·2021-08-17
Ok
Reply
2
Report
RIC
·2021-08-17
good
Reply
3
Report
KYHBKO
·2021-08-17
some regard such moves as defensive ... sitting on over $144 Billion worth of cash ... to swoop in when the prices turned into fair value in anticipation of market correction or more. happy investing all.
Reply
5
Report
ToongMH
·2021-08-17
Good to read
Reply
1
Report
Ahlec
·2021-08-17
Like
Reply
2
Report
冰眼
·2021-08-17
Pls like
Reply
1
Report
Chris68
·2021-08-17
Good to know
Reply
4
Report
Fold Replies
- dt1:
  [微笑]
  2021-08-17
  Reply
  Report
June陈
·2021-08-17
Like.
Reply
3
Report
Fold Replies
- Jackosen:
  done
  2021-08-17
  Reply
  Report
股神不是神
·2021-08-17
Berkshire’s top 10 holdings stayed relatively unchanged in the last quarter. Here’s what they are:
Reply
9
Report
Fold Replies
- Michael8208:
  [Great]
  2021-12-09
  Reply
  Report
- KW1:
  ok
  2021-09-11
  Reply
  Report
- Chris68:
  Good info
  2021-08-17
  Reply
  Report
Blading23
·2021-08-17
Read
Reply
3
Report
Fold Replies
- Blading23:
  comment
  2021-08-17
  Reply
  Report
Targarean
·2021-08-17
Pharma is getting over-valued now with all the focus on vaccine
Reply
4
Report
popcorntan
·2021-08-17
Nice
Reply
3
Report
Lanying
·2021-08-17
O
Reply
2
Report
Fold Replies
- Lanying:
  O
  2021-08-17
  Reply
  Report
mQ
·2021-08-17
Yeah
Reply
2
Report
Rashamon96
·2021-08-17
I think better observe the market for a while.
Reply
3
Report
Fold Replies
- gupzbajaj:
  for sure
  2021-08-17
  Reply
  Report
- mQ:
  ??
  2021-08-17
  Reply
  Report
LIAN230221
·2021-08-17
Please like this and comment thanks
Reply
1
Report
Fold Replies
- 1Robo:
  ok
  2021-08-17
  Reply
  Report
CMF1979
·2021-08-17
When prices are hitting records every now and then.. and everyone is rushing to buy.. it is always a little scary.. ??
Reply
6
Report
Fold Replies
- WCS1981:
  Ya like rIding the rollercoaster in the dark[Sweats]
  2021-08-17
  Reply
  Report
- Phyusin:
  Yeah
  2021-08-17
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2160278089?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-17 07:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2160278089","market":"us","top_or_hot":-1,"title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","media":"Reuters","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n2021-08-17 07:02 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AXTA","symbol_name":"艾仕得涂料系统","start_time":0,"source_url":null,"article_id":"2160278089","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","pubTimestamp":1629154978,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AXTA":"艾仕得涂料系统","AON":"怡安保险","ABBV":"艾伯维公司","BRK.A":"伯克希尔","GM":"通用汽车","BRK.B":"伯克希尔B","MRK":"默沙东","OGN":"Organon & Co","KR":"克罗格","BMY":"施贵宝","CVX":"雪佛龙","BIIB":"渤健公司","LBTYA":"自由全球","MMC":"威达信集团","RH":"Restoration Hardware Holdings"},"translate_title":"巴菲特旗下的伯克希尔哈撒韦出售药品，出售生化基因的Axalta","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"AON":0.9,"AXTA":0.9,"BIIB":0.9,"BMY":0.9,"BRK.A":0.9,"BRK.B":0.9,"CVX":0.9,"GM":0.9,"KR":0.9,"LBTYA":0.9,"MMC":0.9,"MRK":0.9,"OGN":0.9,"RH":0.9},"content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","kind":"highlight","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":839776080,"gmtCreate":1629186265540,"gmtModify":1676529958286,"author":{"id":"3579922554249988","authorId":"3579922554249988","name":"Portfolio50","avatar":"https://static.tigerbbs.com/3e41399b7d47310e4bf55e2a5917c9da","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579922554249988","authorIdStr":"3579922554249988"},"htmlText":"Net seller of stocks and that much cash - not a good sign! Gonna be taking money off the table too (once target profits are hit).","listText":"Net seller of stocks and that much cash - not a good sign! Gonna be taking money off the table too (once target profits are hit).","text":"Net seller of stocks and that much cash - not a good sign! Gonna be taking money off the table too (once target profits are hit).","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839776080","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839434431,"gmtCreate":1629172361123,"gmtModify":1676529953438,"author":{"id":"3583377018896117","authorId":"3583377018896117","name":"bernardtayet","avatar":"https://static.tigerbbs.com/43e8c1fc37a4bff2a94af98953cff267","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3583377018896117","authorIdStr":"3583377018896117"},"htmlText":"Good to follow up&nbsp;","listText":"Good to follow up&nbsp;","text":"Good to follow up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839434431","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839497804,"gmtCreate":1629171646608,"gmtModify":1676529953218,"author":{"id":"3575453671192179","authorId":"3575453671192179","name":"sickeninglim","avatar":"https://static.tigerbbs.com/0753a2906468fc16c39e5f831b2200d7","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":1,"idStr":"3575453671192179","authorIdStr":"3575453671192179"},"htmlText":"Wow......","listText":"Wow......","text":"Wow......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839497804","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839526426,"gmtCreate":1629167730965,"gmtModify":1676529951868,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575091428590185","authorIdStr":"3575091428590185"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839526426","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839580973,"gmtCreate":1629166172092,"gmtModify":1676529951263,"author":{"id":"3586229488061125","authorId":"3586229488061125","name":"RIC","avatar":"https://static.tigerbbs.com/40f79c31af5e7623d32535c3123b12c2","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0,"idStr":"3586229488061125","authorIdStr":"3586229488061125"},"htmlText":"good&nbsp;","listText":"good&nbsp;","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839580973","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839516633,"gmtCreate":1629165931222,"gmtModify":1676529951013,"author":{"id":"3574381076586256","authorId":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3574381076586256","authorIdStr":"3574381076586256"},"htmlText":"some regard such moves as defensive ... sitting on over $144 Billion worth of cash ... to swoop in when the prices turned into fair value in anticipation of market correction or more. happy investing all.&nbsp;","listText":"some regard such moves as defensive ... sitting on over $144 Billion worth of cash ... to swoop in when the prices turned into fair value in anticipation of market correction or more. happy investing all.&nbsp;","text":"some regard such moves as defensive ... sitting on over $144 Billion worth of cash ... to swoop in when the prices turned into fair value in anticipation of market correction or more. happy investing all.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839516633","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839513755,"gmtCreate":1629165781577,"gmtModify":1676529950951,"author":{"id":"3579230468032082","authorId":"3579230468032082","name":"ToongMH","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579230468032082","authorIdStr":"3579230468032082"},"htmlText":"Good to read","listText":"Good to read","text":"Good to read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839513755","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839597276,"gmtCreate":1629165139795,"gmtModify":1676529950651,"author":{"id":"4091753544363040","authorId":"4091753544363040","name":"Ahlec","avatar":"https://static.tigerbbs.com/81afb03fdd19de870e28208208ff7909","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4091753544363040","authorIdStr":"4091753544363040"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839597276","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839250534,"gmtCreate":1629162755428,"gmtModify":1676529949424,"author":{"id":"3579425593342076","authorId":"3579425593342076","name":"冰眼","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579425593342076","authorIdStr":"3579425593342076"},"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839250534","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839233387,"gmtCreate":1629160255949,"gmtModify":1676529948022,"author":{"id":"3575974639321365","authorId":"3575974639321365","name":"Chris68","avatar":"https://static.tigerbbs.com/1ae39a12c3ba237f3b001689ec9a549b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3575974639321365","authorIdStr":"3575974639321365"},"htmlText":"Good to know&nbsp;","listText":"Good to know&nbsp;","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/839233387","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549905,"gmtCreate":1629160856741,"gmtModify":1663232476550,"authorId":3577530901336464,"author":{"id":3577530901336464,"idStr":"3577530901336464","authorId":3577530901336464,"name":"dt1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839233387,"type":1,"supId":0,"prevId":0,"content":"[微笑]","text":"[微笑]","html":"[微笑]"}],"langContent":"EN"},{"id":839295117,"gmtCreate":1629160033939,"gmtModify":1676529947919,"author":{"id":"4087997917943030","authorId":"4087997917943030","name":"June陈","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087997917943030","authorIdStr":"4087997917943030"},"htmlText":"Like.","listText":"Like.","text":"Like.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/839295117","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549823,"gmtCreate":1629160520237,"gmtModify":1663232478248,"authorId":3581544848503089,"author":{"id":3581544848503089,"idStr":"3581544848503089","authorId":3581544848503089,"name":"Jackosen","avatar":"https://static.tigerbbs.com/89f363319ae263a7271cb94a537d8d68","vip":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.03","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839295117,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":839645579,"gmtCreate":1629158675091,"gmtModify":1676529947125,"author":{"id":"3496272380555209","authorId":"3496272380555209","name":"股神不是神","avatar":"https://static.tigerbbs.com/cde0620da82946300393ff9a17e580b1","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3496272380555209","authorIdStr":"3496272380555209"},"htmlText":"Berkshire’s top 10 holdings stayed relatively unchanged in the last quarter. Here’s what they are:","listText":"Berkshire’s top 10 holdings stayed relatively unchanged in the last quarter. Here’s what they are:","text":"Berkshire’s top 10 holdings stayed relatively unchanged in the last quarter. Here’s what they are:","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/839645579","repostId":2160278089,"repostType":2,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6906885,"gmtCreate":1639011887874,"gmtModify":1663238316251,"authorId":3578667349403450,"author":{"id":3578667349403450,"idStr":"3578667349403450","authorId":3578667349403450,"name":"Michael8208","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839645579,"type":1,"supId":5825286,"prevId":0,"content":"[Great]","text":"[Great]","html":"[Great]"},{"id":5825286,"gmtCreate":1631319547820,"gmtModify":1663233697172,"authorId":3563714281601583,"author":{"id":3563714281601583,"idStr":"3563714281601583","authorId":3563714281601583,"name":"KW1","avatar":"https://static.tigerbbs.com/094e3f8fd8b3de3da976515926ed1403","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.75%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839645579,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5549748,"gmtCreate":1629160287750,"gmtModify":1663232476251,"authorId":3575974639321365,"author":{"id":3575974639321365,"idStr":"3575974639321365","authorId":3575974639321365,"name":"Chris68","avatar":"https://static.tigerbbs.com/1ae39a12c3ba237f3b001689ec9a549b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839645579,"type":1,"supId":0,"prevId":0,"content":"Good info","text":"Good info","html":"Good info"}],"langContent":"EN"},{"id":839646398,"gmtCreate":1629158578914,"gmtModify":1676529947070,"author":{"id":"3565700003213382","authorId":"3565700003213382","name":"Blading23","avatar":"https://community-static.tradeup.com/news/4cd7ba668d1c755bf79285b205abdfb2","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3565700003213382","authorIdStr":"3565700003213382"},"htmlText":"Read","listText":"Read","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/839646398","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549334,"gmtCreate":1629158588470,"gmtModify":1663232476146,"authorId":3565700003213382,"author":{"id":3565700003213382,"idStr":"3565700003213382","authorId":3565700003213382,"name":"Blading23","avatar":"https://community-static.tradeup.com/news/4cd7ba668d1c755bf79285b205abdfb2","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839646398,"type":1,"supId":0,"prevId":0,"content":"<u>comment</u>","text":"<u>comment</u>","html":"<u>comment</u>"}],"langContent":"EN"},{"id":839628586,"gmtCreate":1629157686645,"gmtModify":1676529946439,"author":{"id":"3573540190522229","authorId":"3573540190522229","name":"Targarean","avatar":"https://community-static.tradeup.com/news/59de1c73df3e7e460bd84cc786850fa6","vip":1,"hat":"https://static.tigerbbs.com/ae1f49570794979e009a5efdeb6f4789","crmLevel":7,"crmLevelSwitch":1,"idStr":"3573540190522229","authorIdStr":"3573540190522229"},"htmlText":"Pharma is getting over-valued now with all the focus on vaccine","listText":"Pharma is getting over-valued now with all the focus on vaccine","text":"Pharma is getting over-valued now with all the focus on vaccine","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839628586","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839664833,"gmtCreate":1629157433123,"gmtModify":1676529946314,"author":{"id":"4090410321908320","authorId":"4090410321908320","name":"popcorntan","avatar":"https://static.tigerbbs.com/d6e61ad57d3baed80233319151786bf6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4090410321908320","authorIdStr":"4090410321908320"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839664833","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839664347,"gmtCreate":1629157427289,"gmtModify":1676529946314,"author":{"id":"3571641801586244","authorId":"3571641801586244","name":"Lanying","avatar":"https://static.tigerbbs.com/44079e6feb39117800ea99462f8cae40","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3571641801586244","authorIdStr":"3571641801586244"},"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/839664347","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549083,"gmtCreate":1629157434201,"gmtModify":1663232473237,"authorId":3571641801586244,"author":{"id":3571641801586244,"idStr":"3571641801586244","authorId":3571641801586244,"name":"Lanying","avatar":"https://static.tigerbbs.com/44079e6feb39117800ea99462f8cae40","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839664347,"type":1,"supId":0,"prevId":0,"content":"O","text":"O","html":"O"}],"langContent":"EN"},{"id":839665145,"gmtCreate":1629157343887,"gmtModify":1676529946279,"author":{"id":"3575883708634905","authorId":"3575883708634905","name":"mQ","avatar":"https://static.tigerbbs.com/f15c6544cce801bf2702a439bc97d760","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575883708634905","authorIdStr":"3575883708634905"},"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839665145","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":839668664,"gmtCreate":1629157206858,"gmtModify":1676529946212,"author":{"id":"3586937187491404","authorId":"3586937187491404","name":"Rashamon96","avatar":"https://static.tigerbbs.com/c800b60e9a6b67f29f6a9438054010ae","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586937187491404","authorIdStr":"3586937187491404"},"htmlText":"I think better observe the market for a while.&nbsp;","listText":"I think better observe the market for a while.&nbsp;","text":"I think better observe the market for a while.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/839668664","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549504,"gmtCreate":1629159356983,"gmtModify":1663232474233,"authorId":3582203097187155,"author":{"id":3582203097187155,"idStr":"3582203097187155","authorId":3582203097187155,"name":"gupzbajaj","avatar":"https://static.tigerbbs.com/b0441cdcbc87c9f271dee51139b52dff","vip":1,"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839668664,"type":1,"supId":5549070,"prevId":0,"content":"for <u>sure</u>","text":"for <u>sure</u>","html":"for <u>sure</u>"},{"id":5549070,"gmtCreate":1629157362400,"gmtModify":1663232471642,"authorId":3575883708634905,"author":{"id":3575883708634905,"idStr":"3575883708634905","authorId":3575883708634905,"name":"mQ","avatar":"https://static.tigerbbs.com/f15c6544cce801bf2702a439bc97d760","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839668664,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"}],"langContent":"EN"},{"id":839688341,"gmtCreate":1629156672383,"gmtModify":1676529945982,"author":{"id":"3577137894024224","authorId":"3577137894024224","name":"LIAN230221","avatar":"https://static.tigerbbs.com/2e67ec99c7595bec06dd19e19f03d461","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577137894024224","authorIdStr":"3577137894024224"},"htmlText":"Please like this and comment thanks&nbsp;","listText":"Please like this and comment thanks&nbsp;","text":"Please like this and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/839688341","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549018,"gmtCreate":1629157132203,"gmtModify":1663232473137,"authorId":3581571479581183,"author":{"id":3581571479581183,"idStr":"3581571479581183","authorId":3581571479581183,"name":"1Robo","avatar":"https://static.tigerbbs.com/d6d78c3153b562ef72e04f138b8a4f8a","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839688341,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":839612359,"gmtCreate":1629156347871,"gmtModify":1676529945740,"author":{"id":"3555712957170421","authorId":"3555712957170421","name":"CMF1979","avatar":"https://static.tigerbbs.com/9f790768b1730c5db068581be7a710d7","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3555712957170421","authorIdStr":"3555712957170421"},"htmlText":"When prices are hitting records every now and then.. and everyone is rushing to buy.. it is always a little scary.. ??","listText":"When prices are hitting records every now and then.. and everyone is rushing to buy.. it is always a little scary.. ??","text":"When prices are hitting records every now and then.. and everyone is rushing to buy.. it is always a little scary.. ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/839612359","repostId":2160278089,"repostType":4,"repost":{"id":"2160278089","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629154978,"share":"https://ttm.financial/m/news/2160278089?lang=&edition=fundamental","pubTime":"2021-08-17 07:02","market":"us","language":"en","title":"Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2160278089","media":"Reuters","summary":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated i","content":"<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire pares drug holdings, sheds Axalta, Biogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-17 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc&nbsp;said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck &amp; Co spinoff, Organon &amp; Co.</p>\n<p>In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.</p>\n<p>It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.</p>\n<p>The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.</p>\n<p>Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.</p>\n<p>That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.</p>\n<p>The Standard &amp; Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.</p>\n<p>Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.</p>\n<p>The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.</p>\n<p>Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.</p>\n<p>Berkshire reported a $46.9 million Organon stake as of June 30.</p>\n<p>Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.</p>\n<p>In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh &amp; McLennan Cos and US Bancorp.</p>\n<p>It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AON":"怡安保险","BRK.A":"伯克希尔","KR":"克罗格","GM":"通用汽车","RH":"Restoration Hardware Holdings","BRK.B":"伯克希尔B","ABBV":"艾伯维公司","CVX":"雪佛龙","BIIB":"渤健公司","MRK":"默沙东","MMC":"威达信集团","AXTA":"艾仕得涂料系统","LBTYA":"自由全球","OGN":"Organon & Co","BMY":"施贵宝"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160278089","content_text":"Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.\nIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.\nIt also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.\nThe changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.\nBerkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.\nThat suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.\nThe Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.\nBerkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.\nThe Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.\nOrganon specializes in contraception and other women's health products, and has dozens of brands in other fields.\nBerkshire reported a $46.9 million Organon stake as of June 30.\nIts largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.\nIn Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.\nIt reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5549313,"gmtCreate":1629158506647,"gmtModify":1663232474074,"authorId":3582764273979695,"author":{"id":3582764273979695,"idStr":"3582764273979695","authorId":3582764273979695,"name":"WCS1981","avatar":"https://static.tigerbbs.com/f98e28d5b1695429dd1657ecc78f93f5","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839612359,"type":1,"supId":0,"prevId":0,"content":"Ya like rIding the rollercoaster in the dark[Sweats]","text":"Ya like rIding the rollercoaster in the dark[Sweats]","html":"Ya like rIding the rollercoaster in the dark[Sweats]"},{"id":5549112,"gmtCreate":1629157572159,"gmtModify":1663232471546,"authorId":3584490239949882,"author":{"id":3584490239949882,"idStr":"3584490239949882","authorId":3584490239949882,"name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":839612359,"type":1,"supId":0,"prevId":0,"content":"Yeah ","text":"Yeah ","html":"Yeah "}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":266,"commentSize":27,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}